MTI is a Canadian based company leader in smart materials and photonics, involved in sources and instruments for light-signaling filters. The company designs and develops optical fibers and metamaterial-based systems. Mediwise, based in London, is a medical research and development company which pioneers wireless medical devices for diagnostic and monitoring purposes. This transaction will strengthen MTI’s position in the advanced materials market.

Medical and Healthcare Products Expo “Medical Fair Thailand” will be held for the 9th time between 11 – 13 September 2019 at BITEC, Bangkok. Messe Düsseldorf Asia one of Messe Düsseldorf affiliated, the leader of leading medical and healthcare organizer such as MEDICA, will be the host.

The International Symposium on Medical Robotics (ISMR 2019) will be held at the Academy of Medicine in Atlanta, Georgia, USA, from 3-5 April 2019. The goal of this Symposium is to bring together engineers, clinicians and industry in various fields of medical robotics to create a common forum for exchanging ideas and foster future developments in medical robotics. 

Research conducted at the Scripps Translational Science Institute in the United States indicated that wearing an ECG patch improved diagnosis speed of atrial fibrillation (AFib) in high-risk patients. This device could reduce the risk of strokes in AFib patients and also help to mitigate the condition. A research document entitled ‘mHealth Screening to Prevent Strokes (mSToPS)

This cell therapy conference will be held from 18-20 September 2018 in Seoul, South Korea.
Cell Therapy World Asia 2018 will bring together the best technology in Asia concerning cell therapy development and manufacturing. Cell therapy companies from South Korea, Japan, China, India, Singapore, Taiwan and other Asian countries will discuss and debate on best practices and innovations in this field.

Merck is planning an additional investment of $49.3 million to strengthen its manufacturing and distribution platform in Asia over the next two years. This latest cash input follows the November 2016 announcement of its $98.6 million Life Science investment in Nantong, China.

Sanofi plans the launch of a Global R&D Operations Hub with specialized focus on digitalization and big data analysis in Chengdu, Sichuan Province, China. This new hub will become the third pillar of the company’s research and development operation, joining current facilities in France and the United States.

Secretary of Chao Phraya Aphaiphubet Hospital charity, Pharmacist Dr. Suphaporn Pitiporn declare about Chao Phraya Aphaiphubet Hospital charity marketing plan which has to be change due to Thailand government policy to be a leader country in herbal market. The new marketing plan is an offensive plan that increasing investment on manufacturing machine to use in 16 herbal production line such as Indian Gooseberry cough syrups,